Project Details
Description
The completion of this subproject will provide important support for the feasibility of our MFP-based proprietary culture system for generating enhanced MSCs for treating DCLI. Also, the secretome of eMSCs will shed light on the molecular networks underlying eMSC-associated therapeutic functions.
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/22 → 7/31/23 |
Keywords
- Diabetes-associated critical limb ischemia (DCLI)
- MFP-enhanced mesenchymal stem cells (eMSCs)
- secretome
- small extracelluar vesicles (sEVs)
- new therapeutics development
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.